Given the high burden of pro-inflammatory comorbidities known to be associated with higher CRP levels in the RELAX HFpEF cohort and the fairly advanced nature of the HF in the RELAX cohort, it is perhaps surprising that 40% of HFpEF patients did not have elevated CRP. The gene discussed is CRP; the disease is hydrops fetalis.